Syndax Pharmaceuticals Inc (NASDAQ:SNDX) Is Currently -171.91% Below Its 52-Week High, But Upside Potential Is Still There.
In recent trading session, Syndax Pharmaceuticals Inc (NASDAQ:SNDX) saw 0.63 million shares changing hands at last check today with its beta currently measuring 0.72. Company’s